ENTITY
JW Therapeutics

JW Therapeutics (2126 HK)

39
Analysis
Health CareChina
JW (Cayman) Therapeutics Co. Ltd operates as a clinical stage therapy platform company. The Company offers developing, manufacturing and commercializing breakthrough cell-based immunotherapies forhematological cancers and solid tumors. JW (Cayman) Therapeutics provides services in China.
more
Refresh
bearishYSB
23 Jun 2024 15:59

China Healthcare Weekly (Jun23)-Retail Pharmacy's Dilemma, Logic to Biotech's Stock Price,YSB's Risk

​Retail pharmacies facing industry clearance due to negative policies.Biotech stock performance tied to sustainable development path. YSB faces...

Logo
336 Views
Share
01 Jun 2023 08:55

CARSgen Therapeutics (2171.HK) - Pain Points Have Not Been Effectively Resolved

We hope investors can understand the practical problems in CAR-T field, and whether it can provide effective clinical needs. CARsgen is hard to...

Logo
331 Views
Share
25 Feb 2023 16:00

HSCI Index Rebalance: 35 Adds, 28 Deletes & Changes to Southbound Stock Connect

There are 35 adds & 28 deletes for the HSCI in March leading to 29 adds & 20 deletes for Stock Connect. 19 index constituents could be dropped from...

Logo
622 Views
Share
bullishJW Therapeutics
23 Jan 2023 09:26

China Healthcare Weekly (Jan.20) - NRDL Negotiation Results, JW Therapeutics, Sirnaomics, Antengene

We analyzed 2022 NRDL negotiation result - There're positive sides.The "safety pad" brought by medical insurance coverage may not be high.We...

Logo
420 Views
Share
04 Jan 2023 06:29

HSCI Index Rebalance Preview and Stock Connect: A Lot of Change

We forecast 44 adds/19 deletes for the HSCI in March leading to 37 adds/deletes for Southbound Stock Connect. There could be more Connect changes...

Logo
813 Views
Share
x